1.The Long Term Results of Augmentation Cystoplasty in Contracted Bladder.
Jeong Hyun KIM ; Eun Chan PARK ; Sang Eun LEE
Korean Journal of Urology 2001;42(1):59-64
PURPOSE: In contracted bladder of various etiologies, if many of conservative managements fail, a surgical treatment seems to be the only therapeutic approach. We tried to evaluate the long term results of aug mentation cystoplasty including the postoperative complication and the degree of satisfaction in patients. MATERIALS AND METHODS: From 1989 to 1988, augmentation cystoplasties had been performed in 11 patients with contracted bladder of various etiologies. We reviewed the patients' medical records including the result of urodynamic examinations, retrospectively. Postoperative follow-up periods were 9 to 114months (mean:61months). Patients were interviewed by telephone. RESULTS: Urinary frequency, nocturia, dysuria and suprapubic pain were improved in all patients, but dysuria persisted in one patient with tuberculous cystitis. Clean intermittent catheterization (CIC) was done in there of 11 patients due to large volume of residual urine. The volume of residual urine was 200-300ml in one with hyperreflexic neurogenic bladder, and 100-200ml in two with interstitial cystitis. Self voiding was possible in 8 patients with residual urine volume less than 90ml. Almost all patients were very satisfied symptomatically in the telephone survey. There were no significant complications which required surgical revision. CONCLUSIONS: It is concluded that augmentation cystoplasty could be an excellent method of treatment for selective patients with contracted bladder, who have not improved symtomatically by medication or conservative management.
Cystitis
;
Cystitis, Interstitial
;
Dysuria
;
Follow-Up Studies
;
Humans
;
Intermittent Urethral Catheterization
;
Medical Records
;
Nocturia
;
Postoperative Complications
;
Reoperation
;
Retrospective Studies
;
Telephone
;
Urinary Bladder*
;
Urinary Bladder, Neurogenic
;
Urodynamics
2.The Relation Between the Occupational Stress and Fatigue Level of Neonatal Nurses.
Korean Journal of Occupational Health Nursing 2011;20(3):261-269
PURPOSE: The purpose of this study was to investigate occupational stress and fatigue level of neonatal nurses and to assess relationship between the two of them. METHODS: Subjects were 109 neonatal nurses working at 2 university hospitals and 9 women's hospitals in D city, and the data were analyzed using descriptive statistics and binary logistic regression analysis by the SPSS/WIN 15.0. RESULTS: The mean score of nurses' occupational stress level was 3.22, and the highest was 'night shift' among the 7 subcategories, and fatigue level was 62.0, and the highest was physical fatigue in configuration field. In logistic regression analyses, 'heavy workload' and 'inadequate physical environment' led to most occupational stress. CONCLUSION: In addition to significantly higher levels of occupational stress of neonatal nurses, the cumulative fatigue also resulted in decreased quality of nursing, job satisfaction and nursing productivity; therefore, appropriate number of nurses and improvement of work environment is necessary. Furthermore, to reduce the occupational stress and fatigue, we should try to develop adequate clinical guidelines and intervention strategies and apply them in neonatal care unit.
Fatigue
;
Hospitals, University
;
Infant, Newborn
;
Job Satisfaction
;
Logistic Models
;
Neonatal Nursing
3.Transrectal Ulterasonographic Parameters Prediciting Acute Urinary Retention in BPH.
Jeong Yoon KANG ; Moon Soo PARK ; Sang Eun LEE
Korean Journal of Urology 2000;41(12):1485-1489
No abstract available.
Urinary Retention*
4.Diagnositc Value of Stable Microbubble Rating test and Efficacy of Surfactant Replacement Therapy in Neonates with Respiratory Distres Syndromes.
Jeong Hee KIM ; Eun Ae PARK ; Ktung Hee KIM
Journal of the Korean Pediatric Society 1995;38(6):760-770
No abstract available.
Humans
;
Infant, Newborn*
;
Microbubbles*
5.A case of type 4 renal tubular acidosis resulting from captopril administration.
Jeong Eun PARK ; Gyu Bog CHOI ; Kyun Il YOON
Korean Journal of Nephrology 1991;10(4):620-624
No abstract available.
Acidosis, Renal Tubular*
;
Captopril*
6.The vreference ranges and clinical usefulness of "free erythrocyte protoporphrin" test.
Jeong Ho KIM ; Q Eun PARK ; Oh Hun KWON
Korean Journal of Clinical Pathology 1993;13(1):13-18
No abstract available.
Erythrocytes*
7.The vreference ranges and clinical usefulness of "free erythrocyte protoporphrin" test.
Jeong Ho KIM ; Q Eun PARK ; Oh Hun KWON
Korean Journal of Clinical Pathology 1993;13(1):13-18
No abstract available.
Erythrocytes*
8.The vreference ranges and clinical usefulness of "free erythrocyte protoporphrin" test.
Jeong Ho KIM ; Q Eun PARK ; Oh Hun KWON
Korean Journal of Clinical Pathology 1992;12(1):13-18
No abstract available.
Erythrocytes*
9.Clinical Aspect of Suspected HNPCC in Korea.
Eun Jeong LEE ; Young Jin PARK ; Kyu Joo PARK ; Jae Gahb PARK
Journal of the Korean Society of Coloproctology 1998;14(3):331-340
PURPOSE: The criteria for Suspected hereditary nonpolyposis colorectal cancer(Suspected HNPCC) has been devised by the Korean Hereditary Tumor Registry for families who do not fulfill Amsterdam criteria, but hereditary background is strongly suggested. This study was performed to define the clinical characteristics of 'Suspected HNPCC'. METHODS: The 'Suspected HNPCC' criteria include the followings: a) vertical transmission of colorectal cancer or at least two siblings affected with colorectal cancer in a family and b) development of multiple colorectal tumors (including adenoma) or at least one colorectal cancer case diagnosed before the age of 50 years or development of extracolonic cancers (endometrium, urinary tract, small intestine, stomach, hepatobiliary system, ovary) in family members. We analysed the clinical characteristics of 93 patients from 39 Suspected HNPCC families and compared these characteristics with 176 HNPCC familes and with 1,204 non-hereditary colorectal cancer patients. RESULTS: The mean age of Suspected HNPCC patients at the time of diagnosis (49.0 years) was significantly lower than that of non-hereditary colorectal cancer patients (56.1 years), but higher than that of the HNPCC patients (44.5 years). Tumors were more frequently located in the right colon (34%) in Suspected HNPCC compared to non-hereditary colorectal cancer (23%). Dukes' A and B cancers were more frequent in the Suspected HNPCC as compared to non-hereditary colorectal cancer (55% vs. 48%, p<0.05), but tumor differentiation was not statistically different between the two groups. Among the Suspected HNPCC, 24.0% of the patients had synchronous adenomatous polyps and 20.0% had synchronous colorectal cancers and 15.6% had metachronous polyps or cancers. These findings were similar to HNPCC, but significantly higher than non-hereditary colorectal cancers (p<0.05). In Suspected HNPCC families, 42 patients had extracolonic malignancies with the stomach cancer being the most common (n=22). CONCLUSION: These data indicate that the clinical characteristics of Suspected HNPCC are similar to those of HNPCC and may suggest that the management principles of the HNPCC should also be applied to the Suspected HNPCC.
Adenomatous Polyps
;
Colon
;
Colorectal Neoplasms
;
Diagnosis
;
Humans
;
Intestine, Small
;
Korea*
;
Polyps
;
Siblings
;
Stomach
;
Stomach Neoplasms
;
Urinary Tract
10.The Expression of Vascular Endothelial Growth Factor and Thrombospondin-1 in Wilms' Tumor.
Seong Jin JEONG ; Eun Chan PARK ; Cheol KWAK ; Ren jie JIN ; Sang Eun LEE ; Hwang CHOI
Korean Journal of Urology 2001;42(3):265-272
PURPOSE: With the process of neoangiogenesis being linked to the growth and metastasis of various tumors, anticancer therapeutics with a basis in the suppression of neoangiogenesis has recently been receiving attention. In this study, we tried to clarify the immunoreactivities of vascular endothelial growth factor (VEGF), major angiogenic inducer and thrombospondin-1 (TSP-1), major angiogenic inhibitor in human Wilms' tumor and its clinicopathological significance. MATERAILS AND METHODS: Utilizing immunohistochemical staining, we assessed the immunoreactivities of VEGF and TSP-1 in archival tissues of 29 Wilms' tumors and 25 normal kidneys. Also, we assessed the relationship between expression of each factor and clinicopathological parameters in 29 cases of Wilms' tumors. RESULTS: Immunoreactivities of VEGF and TSP-1 were detected mainly in the cytoplasm of the tubular cells in normal kidneys. In Wilms' tumors, whereas VEGF was detected in the cytoplasm of the tumor cells and peritumoral stromal tissues, but TSP-1 only in the peritumoral stromal tissues. Immunohistochemical expression patterns of each factor were divided into two groups according to the area of immunoreactivity (negative:<10%, positive: > OR =10%). VEGF immunoreactivity was detected in 25 (100%) normal kidneys and in 20 (69%) Wilms' tumors. However, TSP-1 immunoreactivity was detected in 24 (97%) normal kidneys and in 3 (10%) Wilms' tumors. Therefore, although no significant difference was observed between the expressions of VEGF and TSP-1 in normal kidney, the TSP-1 immunoreactivity was significantly lower than VEGF immunoreactivity in Wilms' tumors. A relatively higher rate of positive expression of TSP-1 was observed in the patients with no demonstrable lymph node metastasis. Also, as for the VEGF, maximal diameter of the tumor was larger in the positive expression group. However, it proved otherwise for TSP-1 as the negative expression group demonstrated tumors with larger maximal diameters. CONCLUSIONS: Our study demonstrated that the TSP-1 immunoreactivity was significantly lower than VEGF immunoreactivity in Wilms' tumors, and disease progression has a tendency to be found in the VEGF-positive cases and TSP-1 negative cases. We suggest that the growth and metastasis of Wilms' tumor may be influenced mainly by TSP-1 decrease rather than VEGF increase.
Cytoplasm
;
Disease Progression
;
Humans
;
Kidney
;
Lymph Nodes
;
Neoplasm Metastasis
;
Thrombospondin 1
;
Vascular Endothelial Growth Factor A*
;
Wilms Tumor*